articles
- Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats. 164. 2020
- The novel MAGL inhibitor MJN110 enhances responding to reward-predictive incentive cues by activation of CB1 receptors. 162. 2020
- A novel dopamine D1 receptor agonist excites delay-dependent working memory-related neuronal firing in primate dorsolateral prefrontal cortex. 150:46-58. 2019
- Vaccine blunts fentanyl potency in male rhesus monkeys. 158. 2019
- Δ9-tetrahydrocannabinol attenuates oxycodone self-administration under extended access conditions. 151:127-135. 2019
- Altered brain activity during withdrawal from chronic alcohol is associated with changes in IL-6 signal transduction and GABAergic mechanisms in transgenic mice with increased astrocyte expression of IL-6. 138:32-46. 2018
- Altered hippocampal synaptic function in transgenic mice with increased astrocyte expression of CCL2 after withdrawal from chronic alcohol. 135:113-125. 2018
- Can adjunctive therapies augment the efficacy of endovascular thrombolysis? A potential role for activated protein C. 134:293-301. 2018
- Designer drugs - A continuing chemical (R)evolution. 134:1-3. 2018
- Locomotor and reinforcing effects of pentedrone, pentylone and methylone in rats. 134:57-64. 2018
- Morphological and functional evidence of increased excitatory signaling in the prelimbic cortex during ethanol withdrawal. 133:470-480. 2018
- Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS. 141:55-65. 2018
- Prophylactic vaccination protects against the development of oxycodone self-administration. 138:292-303. 2018
- Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis. 141:181-191. 2018
- CRF modulates glutamate transmission in the central amygdala of naive and ethanol-dependent rats. 125:418-428. 2017
- Cortical and amygdalar neuronal ensembles in alcohol seeking, drinking and withdrawal. 122:107-114. 2017
- Emerging pharmacotherapies for alcohol use disorder. 122:244-253. 2017
- Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice. 125:80-86. 2017
- P/Q-type voltage -gated calcium channels mediate the ethanol and CRF sensitivity of central amygdala GABAergic synapses. 125:197-206. 2017
- Sex differences in responses of the basolateral-central amygdala circuit to alcohol, corticosterone and their interaction. 114:123-134. 2017
- Synaptic targets: Chronic alcohol actions. 122:85-99. 2017
- The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice. 114:156-167. 2017
- Active vaccination attenuates the psychostimulant effects of α-PVP and MDPV in rats. 116:1-8. 2016
- Dependence-induced ethanol drinking and GABA neurotransmission are altered in Alk deficient mice. 107:1-8. 2016
- Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex. 102:92-102. 2016
- Glutamatergic transmission in the central nucleus of the amygdala is selectively altered in Marchigian Sardinian alcohol-preferring rats: Alcohol and CRF effects. 102:21-31. 2016
- Histamine receptor signaling in energy homeostasis. 106:13-19. 2016
- Histamine receptor signaling in energy homeostasis. 106:13-19. 2016
- Inhaled delivery of Δ(9)-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology. 109:112-120. 2016
- Transgenic mice with increased astrocyte expression of IL-6 show altered effects of acute ethanol on synaptic function. 103:27-43. 2016
- Prioritizing the development of mouse models for childhood brain disorders. 100:2-16. 2016
- Characterization of kappa opioid receptor mediated, dynorphin-stimulated [(35)S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting. 99:131-141. 2015
- IL-6 regulation of synaptic function in the CNS. 96:42-54. 2015
- Intravenous self-administration of entactogen-class stimulants in male rats. 99:538-545. 2015
- Intravenous self-administration of mephedrone, methylone and MDMA in female rats. 92:90-97. 2015
- Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus. 99:600-609. 2015
- Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid. 99:705-714. 2015
- Addiction as a stress surfeit disorder. 76:370-382. 2014
- Chronic periadolescent alcohol consumption produces persistent cognitive deficits in rhesus macaques. 86:78-87. 2014
- Kappa opioid receptor activation decreases inhibitory transmission and antagonizes alcohol effects in rat central amygdala. 77:294-302. 2014
- Nicotine aversion: neurobiological mechanisms and relevance to tobacco dependence vulnerability. 76:533-544. 2014
- Adult siRNA-induced knockdown of mGlu(7) receptors reduces anxiety in the mouse. 72:66-73. 2013
- Crebinostat: A novel cognitive enhancer that inhibits histone deacetylase activity and modulates chromatin-mediated neuroplasticity. 64:81-96. 2013
- Comparison of the effects of the GABA(B) receptor positive modulator BHF177 and the GABA(B) receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice. 70:156-167. 2013
- Differences between synaptic plasticity thresholds result in new timing rules for maximizing long-term potentiation. 64:27-36. 2013
- Effects of lurasidone in behavioral models of depression. Role of the 5-HT7 receptor subtype. 70:211-217. 2013
- Enhanced gabaergic transmission in the central nucleus of the amygdala of genetically selected marchigian sardinian rats: Alcohol and crf effects. 67:337-348. 2013
- New insights on neurobiological mechanisms underlying alcohol addiction. 67:223-232. 2013
- Synaptic plasticity in the hippocampus shows resistance to acute ethanol exposure in transgenic mice with astrocyte-targeted enhanced CCL2 expression. 67:115-125. 2013
- The influence of acute and chronic alcohol consumption on response time distribution in adolescent rhesus macaques. 70:12-18. 2013
- The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: Self-administration and locomotor activity in rats. 71:130-140. 2013
- Neuropeptidomics of mouse hypothalamus after imipramine treatment reveal somatostatin as a potential mediator of antidepressant effects. 62:347-357. 2012
- Alterations in the emotional and memory behavioral phenotypes of transient receptor potential vanilloid type 1-deficient mice are mediated by changes in expression of 5-ht1a, gaba(a), and nmda receptors. 62:1034-1043. 2012
- Development of mechanical hypersensitivity in rats during heroin and ethanol dependence: Alleviation by crf1 receptor antagonism. 62:1142-1151. 2012
- Mechanism of H₂ histamine receptor dependent modulation of body temperature and neuronall activity in the medial preoptic nucleus. 63:171-180. 2012
- Stress modulation of drug self-administration: Implications for addiction comorbidity with post-traumatic stress disorder. 62:552-564. 2012
- The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6- (3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl -1-(tetrahy dro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo 3,4-d pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents. 61:665-676. 2011
- Endocannabinoid-mediated synaptic plasticity and addiction-related behavior. 61:1070-1087. 2011
- Huntington's disease is a disorder of the corpus striatum: focus on Rhes (Ras homologue enriched in the striatum). 60:1187-1192. 2011
- Intravenous nicotine self-administration and cue-induced reinstatement in mice: Effects of nicotine dose, rate of drug infusion and prior instrumental training. 61:687-698. 2011
- Mentored and inspired by Mimo: A tribute to Erminio Costa. 60:1003-1006. 2011
- Structure based prediction of subtype-selectivity for adenosine receptor antagonists. 60:108-115. 2011
- The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics. 60:58-65. 2011
- Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure. 58:185-194. 2010
- Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin a poisoned mouse neuromuscular junctions. 58:1189-1198. 2010
- Reduced alcohol drinking in adult rats exposed to sucrose during adolescence. 59:388-394. 2010
- Neurobiological substrates for the dark side of compulsivity in addiction. 56:18-31. 2009
- The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents. 55:908-918. 2008
- Evaluation of fatty acid amides in the carrageenan-induced paw edema model. 54:181-188. 2008
- Morphine-induced analgesic tolerance, locomotor sensitization and physical dependence do not require modification of mu opioid receptor, cdk5 and adenylate cyclase activity. 54:475-486. 2008
- Identification of ginsenoside interaction sites in 5-ht3a receptors. 52:1139-1150. 2007
- Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice. 50:834-844. 2006
- Binding and functional properties of the novel somatostatin analogue KE 108 at native mouse somatostatin receptors. 48:881-893. 2005
- Coupling of human nicotinic acetylcholine receptors alpha 7 to calcium channels in GH3 cells. 48:215-227. 2005
- Endocannabinoids restrict hippocampal long-term potentiation via cb1. 49:660-668. 2005
- Inhibition of cyclooxygenase-2 elicits a cb1-mediated decrease of excitatory transmission in rat ca1 hippocampus. 49:653-659. 2005
- Lack of stimulant and anxiolytic-like effects of ethanol and accelerated development of ethanol dependence in mu-opioid receptor knockout mice. 49:493-501. 2005
- Prolonged nicotine exposure does not alter gaba(b) receptor-mediated regulation of brain reward function. 49:953-962. 2005
- Cathepsin B-like proteolysis and MARCKS degradation in sublethal NMDA-induced collapse of dendritic spines. 47:706-713. 2004
- Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance. 47:1081-1092. 2004
- The somatostatin receptor (sst(1)) modulates the release of somatostatin in the nucleus accumbens of the rat. 47:612-618. 2004
- Biological activity of somatostatin receptors in GC rat tumour somatotrophs: evidence with sst1-sst5 receptor-selective nonpeptidyl agonists. 44:672-685. 2003
- Genetic deletion of somatostatin receptor 1 alters somatostatinergic transmission in the mouse retina. 45:1080-1092. 2003
- Somatostatin sst(2) receptor knock-out mice: localisation of sst(1-5) receptor mRNA and binding in mouse brain by semi-quantitative RT-PCR, in situ hybridisation histochemistry and receptor autoradiography. 42:396-413. 2002
- 5-HT(6) receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine. 42:170-180. 2002
- Both gaba(b) receptor agonist and antagonists decreased brain stimulation reward in the rat. 40:676-685. 2001
- Distinct effect of pregnenolone sulfate on NMDA receptor subtypes. 40:491-500. 2001
- Pharmacological comparison of human homomeric 5-HT3A receptors versus heteromeric 5-HT3A/3B receptors. 41:282-284. 2001
- The effect of autonomous alpha-camkii expression on sensory responses and experience-dependent plasticity in mouse barrel cortex. 41:771-778. 2001
- Cloning, expression and pharmacological characterisation of the mouse somatostatin sst(5) receptor. 39:1451-1462. 2000
- Anxiogenic effects of nicotine in the dorsal hippocampus are mediated by 5-ht1a and not by muscarinic m-1 receptors. 39:300-307. 2000
- Characterisation of the fish sst3 receptor, a member of the SRIF1 receptor family: atypical pharmacological features. 38:449-462. 1999
- No change in NMDA receptor-mediated response rise-time during development: Evidence against transmitter spillover. 37:1393-1398. 1998
- 5-HT receptor classification and nomenclature: Towards a harmonization with the human genome. 36:419-428. 1997
- Inhibition of cAMP accumulation via recombinant human serotonin 5-HT1A receptors: Considerations on receptor effector coupling across systems. 36:429-437. 1997
- Inhibition of nitric oxide synthesis reduces intravenous cocaine self-administration in the rat. 35:1811-1814. 1996
- Actions of redox-related congeners of nitric oxide at the NMDA receptor. 33:1229-1233. 1994
- Sensitivity of the circadian-rhythm of kainic acid-induced convulsion susceptibility to manipulations of corticosterone levels and mineralocorticoid receptor-binding. 33:1087-1093. 1994
- The beta-carboline derivative dmcm decreases gamma-aminobutyric-acid responses and ca2+-mediated k+-conductance in rat neocortical neurons in-vitro. 33:875-883. 1994
- Effects of dizocilpine (MK-801) and ethanol on the EEG and event-related potentials (ERPS) in rats. 31:369-378. 1992
- Precipitation of morphine-withdrawal syndrome in rats by administration of mu-selective, delta-selective and kappa-selective opioid antagonists. 31:1231-1241. 1992
- Levels of dynorphin peptides, substance-p and cgrp in the spinal-cord after subchronic administration of morphine in the rat. 30:1219-1223. 1991
- Subtractive cloning of complementary dnas and analysis of messenger-rnas with regional heterogeneous distributions in primate cortex. 26:845-854. 1987
- Chemical and physiological-aspects of the actions of lithium and anti-depressant drugs. 22:359-365. 1983
- Metabolism of h-3 dopamine following intracerebroventricular injection in rats pretreated with ethanol or chloral hydrate. 22:279-286. 1983
- Benzodiazepine receptors remain unchanged after chronic ethanol administration. 19:125-128. 1980
- Cooperative interactions of histamine and competitive antagonism by cimetidine at neuronal histamine-receptors in the marine mollusk, Aplysia-californica. 18:415-421. 1979
- Relationship between pipradrol-induced responding for electrical brain-stimulation, stereotyped behavior and locomotor-activity. 17:363-366. 1978
- Microiontophoretic release of norepinephrine from micropipettes. 10:175-180. 1971